This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of Toronto directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $100,000
Exploration of variable lymphocyte receptor antibodies as alternative for antibiotic treatment in the gastrointestinal tract
CIHR · 2025 · Nominated PI
- $100,000
COVID-19 Variant Network - Towards a comprehensive understanding of adaptive immunity to SARS-CoV-2
CIHR · 2021 · Principal investigator
- $50,000
COVID-19 Variant Supplement - Towards a comprehensive understanding of adaptive immunity to SARS-CoV-2
CIHR · 2021 · Principal investigator
Exploration of variable lymphocyte receptor antibodies as alternative for antibiotic treatment in the gastrointestinal tract
Principal investigators: Ehrhardt, Rudolf A
Keywords: Antibodies; Cytokine; Evolution; Jawless Vertebrates; Microbiome; Variable Lymphocyte Receptor; Virulence Factor
COVID-19 Variant Network - Towards a comprehensive understanding of adaptive immunity to SARS-CoV-2
Principal investigators: Watts, Tania H; Ehrhardt, Rudolf A; Gommerman, Jennifer L; Martin, Alberto; Ostrowski, Mario A
Keywords: Antibody Dependent Enhancement; B Cell Reperotire; Correlates Of Protection; Covid19; Immune Memory; Neutralizing Antibody; Rna-Seq; Saliva Iga; T Cell Epitopes; Vaccines
COVID-19 Variant Supplement - Towards a comprehensive understanding of adaptive immunity to SARS-CoV-2
Principal investigators: Watts, Tania H; Ehrhardt, Rudolf A; Gommerman, Jennifer L; Martin, Alberto; Ostrowski, Mario A
Keywords: Antibody Dependent Enhancement; B Cell Reperotire; Correlates Of Protection; Covid19; Immune Memory; Neutralizing Antibody; Rna-Seq; Saliva Iga; T Cell Epitopes; Vaccines
Targeting the novel coronavirus SARS-CoV-2 using an ancient antibody system
Principal investigators: Ehrhardt, Rudolf A
Keywords: Diagnostic; Evolution; Monoclonal Antibody; Neutralizing Epitope; Posttranslational Modification; S-Protein; Variable Lymphocyte Receptor (Vlr)
Towards a comprehensive understanding of adaptive immunity to SARS-CoV-2
Principal investigators: Watts, Tania H; Ehrhardt, Rudolf A; Gommerman, Jennifer L; Martin, Alberto; Ostrowski, Mario A
Keywords: Antibody Dependent Enhancement; B Cell Reperotire; Correlates Of Protection; Covid19; Immune Memory; Neutralizing Antibody; Rna-Seq; Saliva Iga; T Cell Epitopes; Vaccines
Interrogation of cell surface antigens on B lineage cells using structurally unique variable lymphocyte receptor antibodies of the evolutionarily distant sea lamprey
Principal investigators: Ehrhardt, Rudolf A
Keywords: B Cells; Biomarker; Cell Surface Receptor; Evolution; Monoclonal Antibody; Posttranslational Modification; Structure-Function Analysis; Tyrosine Sulfation; Variable Lymphocyte Receptor (Vlr)
Regulation of human memory B cell responses by Fc-Receptor like molecules
Principal investigators: Ehrhardt, Rudolf A
Keywords: Antibodies; Antibody Repertoire; Fc Receptor-Like Molecules; Immunoregulation; Memory B Cells; Plasma Cells; Vaccine
Low Cost and Distributed Health Care Applications Based on Cell-free Systems
Principal investigators: Pardee, Keith I
Keywords: Cancer Diagnostics; Drug Resistance Surveillance; Field-Ready Molecular Tools; In Vitro Synthetic Biology; Low Cost And Distributed; Personalized Medicine; Portable Diagnostics; Portable Genotyping; Portable Therapeutic Manufacturing; Protein-Based Therapeutics
Regulation of human memory B cells by Fc receptor-like (FCRL) molecules
Principal investigators: Ehrhardt, Rudolf A
Keywords: Antibodies; Antibody Repertoire; Fcrl; Immunoregulation; Memory B Cells; Signal Transduction
Regulation of human memory B cells by Fc receptor-like (FCRL) molecules
Principal investigators: Ehrhardt, Rudolf A
Keywords: Antibodies; Antibody Repertoire; Fc Receptor-Like Molecules; Immunoreguation; Memory B Cells; Signal Transduction
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.